EAG has decades of experience performing impurity identification and contaminant investigations across all major dosage forms and delivery systems, including unit dose vials (UDVs) and metered dose inhalers (MDIs). When combined with our expertise in method development, method validation and stability testing on active pharmaceutical ingredients (APIs) and drug products (DPs), EAG is the perfect choice to aid in any follow-up support after corrective action is taken. We will also be there to provide solutions to your CMC and Quality Control analytical needs.
EAG uses a wide array of instrumentation and analytical techniques, so we have the right tools to address any type of contaminant or impurity identification, in any formulation.
To enable certain features and improve your experience with us, this site stores cookies on your computer. Please click Continue to provide your authorization and permanently remove this message.